Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07680530 · ClinicalTrials.gov registry record
SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- 45
- Enrollment target
NCT07680530 is a clinical trial that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 45 participants.
The verdict
NCT07680530 is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
Study Summary
The primary purpose of the clinical investigation is to verify the SpO2 accuracy of the Philips AlarX5 SpO2 sensor with Nellcor OxiMax SpO2 Board.
Interventions
- OTHER Evaluation of Oxygen Sensors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-05-28 |
| Est. Completion | 2026-06-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07680530
The ClinicalTrials.gov registry entry for NCT07680530 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Evaluation of Oxygen Sensors is the first listed.
NCT07680530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07680530 about?
NCT07680530 is a clinical study titled "SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)". The primary purpose of the clinical investigation is to verify the SpO2 accuracy of the Philips AlarX5 SpO2 sensor with Nellcor OxiMax SpO2 Board.
What is the current status of trial NCT07680530?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2026-05-28. Estimated completion is 2026-06-24.
What interventions are being tested in trial NCT07680530?
The interventions under investigation include: Evaluation of Oxygen Sensors (OTHER).
Who is sponsoring clinical trial NCT07680530?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.